LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Image: CerTest Biotec has opened a new facility in Spain for R&D and manufacture of molecular diagnostics products (Photo courtesy of CerTest Biotec).

CerTest Biotec Opens New Facility for Diagnostic Products

CerTest Biotec, a biotechnology company focused on the development and manufacturing of IVD diagnostic products, has opened a new facility in Spain for the research, development and manufacture of molecular diagnostics products. More...
31 May 2018

Global Molecular Diagnostics Market to Reach USD 11 Billion by 2023

The global molecular diagnostics market is expected to grow at a CAGR of 8.4% from USD 7.71 billion in 2018 to USD 11.54 billion by 2023, driven by the increasing prevalence of infectious diseases and various types of cancers, rising awareness and acceptance of personalized medicine and companion diagnostics, growth of the biomarker identification market, and advancements in molecular techniques. More...
31 May 2018
DIASOURCE (A Biovendor Company)

Global POC Coag Test Market Driven by Increasing Geriatrics

The global point-of-care (POC) coagulation testing market is projected to grow at a CAGR of over 6% during the period 2018-2022, driven by the growing geriatric population, worldwide, and increasing focus on personalized medicine. These are the latest findings of Technavio Research, a global technology research and advisory company. More...
03 May 2018

Global PCR Market to Surpass USD 7 Billion by 2025

The global polymerase chain reaction market (PCR) was valued at USD 3.7 billion in 2017 and is projected to grow at a CAGR of 8.8% over the forecast period (2017 – 2025) to surpass USD 7.4 billion by 2025. The extensive applications of the PCR laboratory technique in various fields, rising prevalence and incidence of infectious and chronic diseases, and growing need to develop advanced PCR systems for the rapid and inexpensive quantitative detection of target samples are expected to be the key growth drivers of the PCR market during the forecast period. More...
03 May 2018
Image: The FastFinder software is designed to improve workflow using AI-powered automation (Photo courtesy of Siemens Healthcare).

Siemens Healthineers Launches Thermocycler with AI-Powered Software

Siemens Healthineers launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation. More...
26 Apr 2018
Image: Left: Overview of the ARM. A digital camera captures the same field of view (FoV) as the user and passes the image to an attached compute unit capable of running real-time inference of a machine-learning model. The results are fed back into a custom AR display, which is inline with the ocular lens and projects the model output on the same plane as the slide. Right: A picture of the prototype, which has been retrofitted into a typical clinical-grade light microscope (Photo courtesy of Google).

Google Builds AR Microscope for Cancer Detection

A team of researchers at Google LLC has developed a prototype Augmented Reality Microscope (ARM) platform that could help accelerate and democratize the adoption of deep learning tools for pathologists around the world. The platform comprises a modified light microscope that allows for real-time image analysis and presentation of the results of machine learning algorithms directly into the field of view. The ARM can be retrofitted into existing light microscopes in hospitals and clinics using low-cost, readily available components, and without the need for analyzing whole slide digital versions of the tissue. More...
25 Apr 2018
Image: The Second Read (SR) system is designed to identify various cell types and features within whole slide images (Photo courtesy of Ibex Medical Analytics).

AI-Based Cancer Diagnosis System Eliminates Errors

The first-ever artificial intelligence (AI)-based digital pathology diagnostic system has been deployed in a live clinical setting, following a pilot period, in which the system identified isolated major errors in retrospective prostate core needle biopsies (PCNBs) that had been diagnosed as benign. More...
25 Apr 2018
Visit expo >
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Automatic Hematology Analyzer
LABAS F9000
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay

In Other News



LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000 - 2025 Globetech Media.
All rights reserved.
PURITAN MEDICAL